Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2018 072 215.7 |
96 | EP file number | EAKZ | 18 78 5191.0 |
86 | WO file number | WAKZ | PCT/US2018/026699 |
97 | EP publication number | EPN | 3609495 |
87 | WO publication number | WPN | 2018191160 |
54 | Designation/title | TI | NK1-ANTAGONISTENKOMBINATION UND VERFAHREN ZUR BEHANDLUNG VON SYNUKLEINOPATHIEN |
51 | IPC main class | ICM (ICMV) | A61K 31/675 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/5377 (2006.01), A61K 31/428 (2006.01), A61P 25/00 (2006.01), A61P 25/16 (2006.01), A61P 25/28 (2006.01) |
22 | DE application date | DAT | Apr 9, 2018 |
96 | EP application date | EAT | Apr 9, 2018 |
86 | WO application date | WAT | Apr 9, 2018 |
43 | Date of first publication | OT | Oct 18, 2018 |
| Date of publication of grant | PET | Jul 24, 2024 |
71/73 | Applicant/owner | INH | Chase Therapeutics Corporation, Washington, DC 20006, US |
72 | Inventor | IN | CHASE, Thomas N., Washington, District of Columbia 20006, US; CLARENCE-SMITH, Kathleen E., Washington, District of Columbia 20006, US |
74 | Representative | VTR | Schlich, West Sussex BN17 5HS, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762483555 P Apr 10, 2017
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Member states EPGÜ | EPGUE | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, RO, SE, SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000003609495A1 Searchable text:
EP000003609495A1 Original document:
EP000003609495B1 Searchable text:
EP000003609495B1 Original document:
WO002018191160 Searchable text:
WO002018191160 |
43 | Date of first publication | EVT | Oct 18, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Feb 19, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 17, 2024 (Show all update days)(Hide all update days)- Oct 17, 2024
- Representative: changed
- Procedures: EP procedure, EP patent – unitary effect registered, 02.09.2024: changed
- Procedures: EP procedure, EP patent – unitary effect effective, 24.07.2024: changed
- Sep 12, 2024
- Applicant/owner: changed
- Representative: new
- Address for service: deleted
- Due date: deleted
- Member states EPGÜ: new
- Procedures: EP procedure, EP patent – unitary effect registered, 02.09.2024: new
- Procedures: EP procedure, EP patent – unitary effect effective, 24.07.2024: new
- Sep 5, 2024
- Procedures: EP procedure, EP patent – request for unitary effect, 16.08.2024: new
- Aug 8, 2024
- Procedures: Publications, DPMA mention of EP grant, 08.08.2024: new
- Jul 4, 2024; Feb 15, 2024
- Historical data not available for this/these date(s)
- Feb 19, 2020
- Date of the first transfer into DPMAregister
|